Skip to content

FDMT

4D Molecular Therapeutics, Inc.

NASDAQ · USHealthcareBiotechnology
$11.09+0.91%

Price as of Jul 20, 2026

FDMT analysis

4D Molecular Therapeutics, Inc. stock analysis

Published Drillr research and company-specific analysis. Existing articles keep their current URLs and citation behavior.

Analysis for FDMT is not published yet

Browse the public research library while company-specific analysis is being prepared. Explore research